aid: canbridgepharma name: CANbridge Pharmaceuticals description: >- CANbridge Pharmaceuticals (CANbridge Life Sciences Ltd.) is a global, China-based biopharmaceutical company founded in 2012 that focuses on the research, development, and commercialization of transformative therapies for rare diseases and rare oncology. The company in-licenses and develops differentiated drug candidates from around the world for the Chinese and global markets, with a portfolio of approved products and a gene-therapy and enzyme-replacement pipeline. Headquartered in Beijing with offices in Shanghai, Hong Kong, Taiwan, Suzhou, and Burlington, Massachusetts (USA), CANbridge is listed on the Hong Kong Stock Exchange. This profile was added to the API Evangelist network as a portfolio company of the venture firm Qiming; CANbridge publishes no public developer API, SDK, or machine-readable API surface at this time. url: https://raw.githubusercontent.com/api-evangelist/canbridgepharma/refs/heads/main/apis.yml accessModel: pricing: unknown onboarding: unknown trial: false try_now: false public: false label: Unknown confidence: low source: [] generated: '2026-07-22' method: derived image: https://www.canbridgepharma.com/media/images/01_CANbridge_Logo_1.jpg x-type: company x-source: vc-portfolio x-backed-by: - qiming x-tier: stub x-tier-reason: portfolio-lead specificationVersion: '0.20' created: '2026-07-17' modified: '2026-07-18' tags: - Company - Pharmaceuticals - Biotechnology - Rare Disease - Healthcare - Life Sciences - Gene Therapy - Oncology apis: [] maintainers: - FN: Kin Lane email: kin@apievangelist.com - FN: APIs.json email: info@apis.io common: - type: DomainSecurity url: security/canbridgepharma-domain-security.yml - type: Website url: https://www.canbridgepharma.com/en/ - type: PrivacyPolicy url: https://www.canbridgepharma.com/en/privacy-policy/ - type: Blog url: https://www.canbridgepharma.com/en/media-news/press-release/ x-enrichment: date: '2026-07-19' status: backfilled pass: local-v1 note: backfilled from .gitignore signal + verified work evidence